spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  PDI 

 HSMN NewsFeed - 13 Jul 2026
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier(R)
Devices Oncology
 HSMN NewsFeed - 30 Dec 2024
Halozyme Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantig(TM) with ENHANZE(R) for Subcutaneous Use in Most Previously Approved Adult Solid Tumor Opdivo(R) (nivolumab) Indications
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 18 Nov 2024
IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jan 2023
ZielBio Appoints Alan Bash CEO as Company Advances Oncology Therapeutics
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Jun 2021
Senda Biosciences Strengthens Leadership Team with Key Management Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Sep 2020
Blueprint Medicines Strengthens Leadership with Appointment of Fouad Namouni, M.D., as President, Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Aug 2019
Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo(R) (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Apr 2019
OncoSec Announces Advanced Therapy Medicinal Product Classification from the EMA for TAVO(TM) in Refractory Metastatic Melanoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Jan 2019
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Oct 2018
OncoSec Appoints Kellie Malloy Foerter as Chief Clinical Development Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Sep 2018
Halozyme Appoints Bernadette Connaughton To Board Of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Sep 2018
Halozyme Names Benjamin Hickey As Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Aug 2018
Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Aug 2018
Infinity Pharmaceuticals Appoints Samuel Agresta, M.D., M.P.H. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Jun 2018
Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab) in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Sep 2017
Arvinas Appoints Dr. John Houston as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 May 2017
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Mar 2017
Personal Genome Diagnostics' Expanded PlasmaSELECT(TM) 64 Is First Liquid Biopsy Pan-Cancer Profiling Panel to Include MSI Analyses for Immuno-Oncology
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 21 Feb 2017
Bristol-Myers Squibb Appoints Three New Independent Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jan 2017
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Nov 2016
Bristol-Myers Squibb’s Opdivo(R) (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Oct 2016
Bristol-Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) for the Treatment of Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant and Treatment With Brentuximab Vedotin
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Sep 2016
aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J. King, PhD, as Senior Vice President, Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jul 2016
Pernix Therapeutics Announces Reorganization of Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jul 2016
Janssen Announces Clinical Collaboration with Bristol-Myers Squibb to Evaluate Immuno-oncology Combination in Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Jul 2016
Preceptis Medical Launches the Hummingbird(TM) TTS Ear Tube Delivery System
Devices Product Launch
 HSMN NewsFeed - 20 May 2016
Avalon Ventures and COI Pharmaceuticals Announce First Milestones for Sitari Pharmaceuticals and Silarus Therapeutics and Formation of Eighth Company
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Apr 2016
Hematogenix Laboratory Services, LLC (Hematogenix)- Announces the Launch of two U.S. Food and Drug Administration (FDA) Approved PD-L1 Companion Diagnostic Tests to Help Guide Oncologists Using Immuno-Oncology Therapies
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 9 Mar 2016
Valeant Pharmaceuticals Announces The Addition Of Three New Independent Directors To Its Board
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 6 Jan 2016
NextCure, Inc., New Immuno-Oncology Firm, Announces $67 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 24 Nov 2015
European Commission Approves Reconciliation of Indications for nivolumab Under the Opdivo(R) European Marketing Authorization Application
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Nov 2015
Bristol-Myers Squibb Announces U.S. Food and Drug Administration Approval for Opdivo (nivolumab) as a Single Agent for the Treatment of Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Nov 2015
PDI Enters Definitive Agreement to Sell Its Commercial Services Business to Publicis Healthcare Communications Group
Diagnostics Acquisitions
 HSMN NewsFeed - 1 Oct 2015
Bristol-Myers Squibb Receives Approval from the U.S. Food and Drug Administration for the Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen in BRAF V600 Wild-Type Unresectable or Metastatic Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Apr 2015
Bristol-Myers Squibb Receives Positive CHMP Opinion in the European Union for Opdivo (nivolumab) for the Treatment of Advanced Melanoma in Both First-Line and Previously Treated Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 4 Sep 2013
SANUWAVE Appoints Life Sciences Industry Executive, Alan L. Rubino To Its Board
Devices Wound Care Personnel
 HSMN NewsFeed - 23 May 2012
PPD Names David Simmons Chairman and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jul 2010
Radient Pharmaceuticals Enters Into a Letter of Intent to Acquire Provista Diagnostics Inc.
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 15 Apr 2010
John P. Dugan, Founder and Chairman of PDI, Inc., To Retire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jan 2010
Ligand Completes Acquisition of Metabasis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Dec 2009
American Diabetes Association's New Clinical Practice Recommendations Promote A1C as Diagnostic Test for Diabetes
Diagnostics Endocrinology
 HSMN NewsFeed - 27 Oct 2009
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Jun 2009
PDI and The Medical Affairs Company Enter Exclusive Strategic Alliance
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2009
PDI Announces Termination of Promotion Agreement
Biopharmaceuticals
 HSMN NewsFeed - 20 Jan 2009
Metabasis Therapeutics Announces Corporate Restructuring and Workforce Reduction
Biopharmaceuticals
 HSMN NewsFeed - 20 Jun 2008
PDI Announces Retirement of CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2008
PDI Signs Promotion Agreement with Major Pharmaceutical Company
Biopharmaceuticals
 HSMN NewsFeed - 10 Oct 2007
PPD Names VPs for North America and Asia
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2007
Metabasis Announces European Commission Grants Orphan Medicinal Product Designation to MB07133, Its Product Candidate for the Treatment of Primary Liver Cancer
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Oct 2007
Tulip BioMed, Inc. Announces New Pricing Structure for Its Disposable Product Line
Devices
 HSMN NewsFeed - 18 Sep 2007
Tulip BioMed, Inc. Announces Retention of Two Key Regional Independent Distributors for Its Disposable Line of Products
Devices Distribution
 HSMN NewsFeed - 13 Sep 2007
Tulip BioMed, Inc. Announces Introduction of New Product: The Disposable Syringe Lock
Devices
 HSMN NewsFeed - 12 Sep 2007
Tulip BioMed, Inc. Announces Recapitalization and Debt Reorganization Plan
Devices
 HSMN NewsFeed - 10 Sep 2007
Metabasis Announces Orphan Drug Designation Granted to MB07133, Its Product Candidate for the Treatment of Primary Liver Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Jul 2007
PDI Announces New $23 Million Contract Sales Engagement with Top-Five Pharmaceutical Company
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2007
Metabasis Therapeutics Announces Election of George F. Schreiner to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2007
PDI Appoints Nancy Connelly Senior Vice President, Sales Support Services
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2007
Tulip BioMed Announces Recent Appointments to Board of Directors
Devices Personnel
 HSMN NewsFeed - 9 May 2007
Tulip BioMed Appoints New President and Chief Operating Officer; Chief Financial Officer Adds Secretary and Treasurer Titles
Devices Personnel
 HSMN NewsFeed - 20 Apr 2007
PDI Announces Launch of Talent Acquisition Business Unit
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2007
Metabasis Therapeutics Presents Results of a Clinical Study for Its Novel Liver-Targeted Product Candidate for the Treatment of HCC at American Association for Cancer Research
Biopharmaceuticals
 HSMN NewsFeed - 2 Apr 2007
PDI, Inc. Announces Resignation of Steven K. Budd as President, Sales Services
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2007
Industry Leader John Johnson Joins Tulip BioMed Team
Devices Personnel
 HSMN NewsFeed - 27 Feb 2007
PPD Licenses Statin from Ranbaxy Laboratories
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Feb 2007
Orthovita Announces Appointment of Chief Business Officer and Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 11 Jan 2007
Valeant Pharmaceuticals & Metabasis Therapeutics Close Licensing Deal with Schering-Plough Corporation
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Dec 2006
Valeant Pharmaceuticals and Metabasis Therapeutics License Rights to Hepatitis B Compound Pradefovir to Schering-Plough Corporation
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Dec 2006
Schering-Plough Licenses Worldwide Rights to Pradefovir, Oral Hepatitis B Treatment In Development With Valeant Pharmaceuticals and Metabasis Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Nov 2006
PDI, Inc. Announces Appointment of David N. Stievater as Senior Vice President, Emerging Pharma
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2006
Idenix Pharmaceuticals Announces Strategic Collaboration To Enhance Hepatitis C Pipeline
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2006
Tibotec Therapeutics Announces Initiation of the Largest U.S. Clinical Study Examining HIV Treatment in Treatment-Experienced Adult Women
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 26 Sep 2006
Tulip BioMed Board Elects Two New Directors
Devices Personnel
 HSMN NewsFeed - 26 Sep 2006
PDI, Inc. Comments on Status of GlaxoSmithKline Fee for Service Contract Sales Program
Biopharmaceuticals
 HSMN NewsFeed - 12 Sep 2006
Albert J. Pavucek, Jr. Joins Orthovita as Vice President Corporate Controller
Devices Personnel
 HSMN NewsFeed - 11 May 2006
PDI, Inc. Announces a Significant New Contract Sales Engagement With a Major Pharmaceutical Company
Biopharmaceuticals
 HSMN NewsFeed - 9 May 2006
YM Biosciences completes acquisition of Eximias
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 8 May 2006
PDI Announces Appointment of Michael J. Marquard as Chief Executive Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 55

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 55 additional stories matching:
PDI
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!